Genes and Phenotype (GAP) A National Resource for Genotype-Phenotype Studies of Immunological and Inflammatory Pathways
NCT ID: NCT01161056
Last Updated: 2015-09-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
5000 participants
OBSERVATIONAL
2009-05-31
2015-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Role of Genetic Polymorphisms in Innate Immune Response Genes in Susceptibility to Infections
NCT00597090
Genetic Analysis of Immune Disorders
NCT00001467
Novel Genetic Disorders of the Immune System
NCT02257892
Genetic Basis of Primary Immunodeficiencies
NCT00001788
Milieu Intérieur Collection - Genetic & Environmental Determinants Of Immune Phenotype Variance
NCT03905993
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The second purpose is to enroll people who are willing to serve as comparisons in future research studies into the Genotype and Phenotype Research Registry (GAP Registry).
Volunteers are asked to provide information on age, ethnicity and medical history. Volunteers are asked to provide a blood sample of up to 100cc and allow us to contact you about additional studies.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy Control Group
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Generally healthy
Exclusion Criteria
* History of chronic immunodeficiency or chronic viral infections such as Epstein Barr virus, hepatitis or HIV
* Currently undergoing treatment for cancer
* Current treatment with immuno-suppressant drugs
* Pregnancy
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NIH
University of Alabama at Birmingham
OTHER
Northwell Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peter Gregersen
Center Head
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peter Gregersen, MD
Role: PRINCIPAL_INVESTIGATOR
Northwell Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Feinstein Institute for Medical Research
Manhasset, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09-081A
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.